MedPath

The Value of HBA in the Evaluation of Idiopathic Infertility

Not Applicable
Completed
Conditions
Infertility
Interventions
Other: HBA binding assay
Registration Number
NCT01683435
Lead Sponsor
St. Luke's-Roosevelt Hospital Center
Brief Summary

We would like to determine if HBA® testing of sperm in couples with presumed idiopathic infertility will reveal lower binding percentages than in couples with an identifiable cause of infertility either male factor or tubal factor

Detailed Description

We would like to determine if HBA® testing of sperm in couples with presumed idiopathic infertility will reveal lower binding percentages than in couples with an identifiable cause of infertility either male factor or tubal factor We would like to determine if patients with abnormal HBA binding have decreased IVF outcome: decreases clinical pregnancy rate, implantation rate, and increased miscarriage rate

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • . All groups will include females under 40 years of age undergoing 1st IVF cycle 3 groups

    1. Abnormal Semen Analysis (sperm count <10 million/ml and /or rapid progressive motility < 50 %, WHO morphology <30%) normal HSG , normal ovarian reserve testing and ovulation testing
    2. Unexplained infertility- normal ovarian reserve testing and ovulation testing (FSH< 10, AMH>1.0) Normal ovulatory cycles, normal WHO semen analysis. Normal tubes on HSG or Laparoscopy
    3. Tubal infertility as assessed by HSG or laparoscopy
Read More
Exclusion Criteria
  • women over 40, prior failed IVF
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
hylauronin binding assayHBA binding assayHBA binding assay will be preformed on the discarded portion of semen analysis used for IVF.
Primary Outcome Measures
NameTimeMethod
In each of these groups we will assess presence of HBA bound spermimmediate at time of preforming HBA test
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Continuum Reproductive Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath